April 24, 2017 1:23 PM | 1 min read
20-Year Pro Trader Reveals His "MoneyLine"
Ditch your indicators and use the "MoneyLine". A simple line tells you when to buy and sell without the guesswork. It’s a line on a chart that’s helped Nic Chahine win 83% of his options buys. Here's how he does it.
German American Bancorp, Inc. (NASDAQ:GABC) shares tumbled 31.6 percent to $33.64.
CSI Compressco LP (NASDAQ:CCLP) dropped 17.4 percent to $7.69. CSI Compressco lowered its quarterly cash distribution to $0.1875 per outstanding common unit. CSI Compressco is expected to release its Q1 earnings results on Tuesday, May 9, 2017.
Aevi Genomic Medicine, Inc. (NASDAQ:GNMX) shares declined 10.4 percent to $1.38.
Ocwen Financial Corporation (NYSE:OCN) shares fell 9.9 percent to $2.18. Johnson & Weaver, LLP announced investigations of Ocwen and Hain Celestial.
XOMA Corporation (NASDAQ:XOMA) shares dropped 9.3 percent to $7.01 after the company reported results from its Phase 2 proof-of-concept study of prolactin inhibition.
Akari Therapeutics PLC (ADR) (NASDAQ:AKTX) shares declined 8 percent to $18.86. Akari Therapeutics disclosed that it demonstrated positive response with Coversin in its Phase 2 PNH trial.
Changyou.Com Ltd (ADR) (NASDAQ:CYOU) fell 5.7 percent to $28.80 after gaining 9.31 percent on Friday.
bebe stores, inc. (NASDAQ:BEBE) shares declined 5 percent to $3.80 after rising 6.67 percent on Friday.
Gold Fields Limited (ADR) (NYSE:GFI) shares fell 5 percent to $3.65 after dropping 2.04 percent on Friday.
Becton Dickinson and Co (NYSE:BDX) dropped 4.4 percent to $177.15 after the company announced plans to acquire C R Bard for $24 billion.
Mazor Robotics Ltd. (NASDAQ:MZOR) declined 4.2 percent to $34.21. Barclays downgraded Mazor Robotics from Overweight to Equal-Weight.
JERNIGAN CAPITAL, INC. (NYSE:JCAP) declined 4 percent to $23.28. Jefferies initiated coverage on Jernigan Capital with a Hold rating.
20-Year Pro Trader Reveals His "MoneyLine"
Ditch your indicators and use the "MoneyLine". A simple line tells you when to buy and sell without the guesswork. It’s a line on a chart that’s helped Nic Chahine win 83% of his options buys. Here's how he does it.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.